Physical Activity and Education for Colorectal Cancer
(CHALLENGE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine whether a physical activity program, combined with health education materials, is more effective than the materials alone for individuals who have undergone surgery and chemotherapy for colon cancer. The focus is on enhancing physical fitness, mental well-being, and overall quality of life, while also exploring whether these improvements can lower the risk of cancer recurrence. Participants should have completed treatment for high-risk stage II or stage III colon cancer and not currently meet recommended physical activity levels. As an unphased trial, this study provides a unique opportunity for participants to contribute to research that could improve recovery and quality of life after cancer treatment.
Do I have to stop taking my current medications to join the trial?
The trial does not specify if you need to stop taking your current medications, but you cannot be on any concurrent anticancer treatment, including chemotherapy, biological, or targeted agents. You also cannot take medications that the investigator thinks might prevent you from participating in the physical activity program.
What prior data suggests that this physical activity program and health education materials are safe for patients who have undergone colon cancer treatment?
Research has shown that physical activity is generally safe for people with colon cancer. In several studies, exercising after chemotherapy helped people live longer without cancer returning. For example, one study found that patients who exercised after chemotherapy had a 28% lower risk of cancer recurrence. Another study demonstrated that being active during and after treatment reduced the chance of cancer returning.
These findings suggest that exercise is well-tolerated and may improve outcomes for colon cancer survivors. While exercise is not a typical drug treatment, it is safe for most people and may offer additional health benefits.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores the potential benefits of combining physical activity with health education for managing colorectal cancer. Unlike standard treatments that primarily involve surgery, chemotherapy, and radiation, this trial emphasizes lifestyle changes that could enhance overall well-being and potentially improve outcomes for patients. By focusing on physical activity and personalized education, researchers hope to uncover new ways to support patients in their recovery journey, offering a complementary approach that empowers individuals to take an active role in their health.
What evidence suggests that this trial's treatments could be effective for colon cancer?
Research shows that joining a physical activity program can greatly benefit individuals treated for colon cancer. In this trial, one group will participate in a Physical Activity Program while receiving General Health Education Materials. Studies have found that organized exercise programs reduce the chance of cancer returning by 28% compared to only receiving health education materials, which is the focus of the other group in this trial. Regular exercise can also increase the chances of staying cancer-free, with one study reporting an 80.3% survival rate after five years for those who exercised regularly. Additionally, exercise enhances quality of life and physical fitness for colorectal cancer survivors. Overall, staying active after treatment plays a crucial role in preventing cancer recurrence and improving health.678910
Who Is on the Research Team?
Janette Vardy, PhD, FRACP
Principal Investigator
Sydney Cancer Centre at Concord Repatriation General Hospital
Kerry Courneya, PhD
Principal Investigator
University of Alberta
Christopher Booth, MD
Principal Investigator
Cancer Centre of Southeastern Ontario at Kingston General Hospital
Are You a Good Fit for This Trial?
This trial is for patients who've completed certain chemotherapy for high-risk stage II or III colon cancer within the last 60-180 days. They should be able to communicate, complete questionnaires and exercise tests, not meet current physical activity guidelines, and have no evidence of recurring cancer. Pregnant individuals or those planning pregnancy in the next 3 years are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intensive Intervention
Participants undergo 12 mandatory biweekly face-to-face behavior support sessions combined with 12 mandatory supervised physical activity sessions to increase their physical activity goal by 10 MET hours/week.
Reduced Intervention
Participants undergo 12 mandatory biweekly face-to-face or telephone behavior support sessions combined with 12 recommended supervised physical activity sessions to increase their physical activity goal by 20 MET hours/week.
Minimal Intervention
Participants undergo mandatory monthly face-to-face or telephone behavior support sessions combined with recommended supervised physical activity sessions to increase their physical activity goal to a maximum total of 27 MET hours/week.
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Health Education Materials
- Physical Activity Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Canadian Cancer Trials Group
Lead Sponsor
Queen's University, Belfast
Collaborator
Survivorship Research Group
Collaborator